a closer look at lecanemab, donanemab and amyloid
Published 11 months ago • 1.4K plays • Length 54:22Download video MP4
Download video MP3
Similar videos
-
36:22
a closer look at the lecanemab clinical trials | special video episode of dementia matters
-
26:02
a romp through the science - researching what causes alzheimer's and dementia to help beat it
-
29:10
understanding the biology of alzheimer's disease with neuroscience
-
26:22
world alzheimer‘s day research update special
-
38:51
aaic 2023 highlights - day one
-
1:21
dementia research chatathon live - 7th september 2020
-
6:15
dr sam moxon - the aduhelm paradox
-
5:44
dr sam moxon - science operates on evidence, not proof
-
5:32
dr aida suarez-gonzalez - embedding ppi in our readclear tech trial
-
25:20
nhs dementia care and the science behind getting a reliable dementia diagnosis blood test
-
1:03
how donanemab and lecanemab treat alzheimer's disease
-
1:54
find out more about the dementia research charity chatathon - 2nd december 2022
-
28:05
misfolded proteins, nanoparticles to bust amyloid & neurovascular functions
-
6:38
dr sam moxon - how does an idea turn into a clinical product?
-
56:32
discover dementia biomarkers
-
5:32
dr sam moxon - the importance of public trust in science
-
7:11
dr kamar ameen-ali - what neuropathology can tell us about the brain diseases which lead to dementia
-
27:19
beating tau tangles & amyloid beta
-
9:28
dr yvonne couch - blood flow and dementia